Literature DB >> 12176589

One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine.

Wael El Haggan1, N Barthe, B Vendrely, P Chauveau, F Berger, M Aparicio, L Potaux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12176589     DOI： 10.1016/s0041-1345(02)03094-4

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.

Authors:  Angela C Webster; Rebecca C Woodroffe; Rod S Taylor; Jeremy R Chapman; Jonathan C Craig
Journal:  BMJ       Date:  2005-09-12

Review 2.  Tacrolimus: a further update of its use in the management of organ transplantation.

Authors:  Lesley J Scott; Kate McKeage; Susan J Keam; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  Interventions for preventing bone disease in kidney transplant recipients.

Authors:  Suetonia C Palmer; Edmund Ym Chung; David O McGregor; Friederike Bachmann; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2019-10-22

4.  Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.

Authors:  Peter W Schreiber; Heike A Bischoff-Ferrari; Katia Boggian; Marco Bonani; Christian van Delden; Natalia Enriquez; Thomas Fehr; Christian Garzoni; Hans H Hirsch; Cédric Hirzel; Oriol Manuel; Pascal Meylan; Lanja Saleh; Maja Weisser; Nicolas J Mueller
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.